News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
123 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17891)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2415)
July (288)
Day
2 (2)
3 (145)
4 (188)
5 (190)
6 (124)
7 (71)
10 (179)
11 (91)
12 (168)
13 (122)
14 (57)
17 (142)
18 (120)
19 (151)
20 (179)
21 (55)
24 (93)
25 (131)
26 (123)
27 (118)
28 (134)
31 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Press Releases
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer
March 26, 2025
·
34 min read
Press Releases
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment
March 26, 2025
·
13 min read
Press Releases
Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102
March 26, 2025
·
8 min read
Press Releases
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
·
1 min read
Press Releases
Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025
March 26, 2025
·
4 min read
Press Releases
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
March 26, 2025
·
7 min read
Press Releases
Kelun-Biotech’s Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
March 26, 2025
·
3 min read
Press Releases
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
March 26, 2025
·
38 min read
Press Releases
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
March 26, 2025
·
5 min read
Press Releases
Sensorion Announces its Participation at the Van Lanschot Kempen Conference Life Sciences
March 26, 2025
·
3 min read
Previous
11 of 13
Next